SAM
TXG icon

Storebrand Asset Management’s 10x Genomics TXG Stock Holding History

Storebrand Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-486
Closed -$5.68K – 825
2025
Q3 		$5.68K Hold
486
– – ﹤0.01% 796
2025
Q2 		$5.63K Hold
486
– – ﹤0.01% 802
2025
Q1 		$4.24K Hold
486
– – ﹤0.01% 819
2024
Q4 		$6.98K Hold
486
– – ﹤0.01% 818
2024
Q3 		$11K Hold
486
– – ﹤0.01% 847
2024
Q2 		$9.45K Sell
486
-603
-55% -$15.8K ﹤0.01% 848
2024
Q1 		$40.9K Sell
1,089
-274
-20% -$12K ﹤0.01% 821
2023
Q4 		$76.3K Hold
1,363
– – ﹤0.01% 813
2023
Q3 		$56.2K Sell
1,363
-425
-24% -$22.1K ﹤0.01% 823
2023
Q2 		$99.8K Hold
1,788
– – ﹤0.01% 806
2023
Q1 		$99.8K Sell
1,788
-4,221
-70% -$197K ﹤0.01% 801
2022
Q4 		$219K Sell
6,009
-1,741
-22% -$56.9K ﹤0.01% 752
2022
Q3 		$221K Sell
7,750
-715
-8% -$27.2K ﹤0.01% 754
2022
Q2 		$383K Hold
8,465
– – ﹤0.01% 740
2022
Q1 		$644K Sell
8,465
-16,745
-66% -$1.46M ﹤0.01% 711
2021
Q4 		$3.76M Sell
25,210
-1,260
-5% -$193K 0.02% 552
2021
Q3 		$3.85M Buy
26,470
+2,002
+8% +$344K 0.02% 560
2021
Q2 		$4.79M Buy
24,468
+3,137
+15% +$568K 0.02% 524
2021
Q1 		$3.86M Buy
21,331
+13,157
+161% +$2.27M 0.02% 562
2020
Q4 		$1.16M Buy
+8,174
New +$1.19M 0.01% 692

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Storebrand Asset Management's TXG Position: Q4 2025 in Review

Storebrand Asset Management sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 486 shares — an estimated $5.68K sold.

Storebrand Asset Management first reported a position in TXG in Q4 2020 and held it in 20 quarters. The position peaked at $4.79M in Q2 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Storebrand Asset Management reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Storebrand Asset Management sold 486 10x Genomics shares in Q4 2025, an estimated $5.68K.
  • Storebrand Asset Management first reported a position in 10x Genomics in Q4 2020 and held it in 20 quarters.
  • Storebrand Asset Management's 10x Genomics position peaked at $4.79M in Q2 2021.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Storebrand Asset Management's 13F filing for Q4 2025, filed 20 May 2026.